Programme

Programme

A bridge between the pathology and physiology of the melanocyte
12-14 September – ESPCR Meeting 2019

12 SEPTEMBER

  • 15.00 – 15.15 - Welcome & Opening Remarks – Autorium Albert II
    Véronique del Marmol, Congress Chair
    Pierre Coulie, President of the Académie de Médecine
    Lluis Montoliu, President of ESPCR
  • 15.15 - 16.45 - PLENARY SESSIONS: A bridge between melanocyte pathology and physiology - Session 1
    • Chair: Véronique del Marmol, Lluis Montoliu, Pierre Coulie
  • 15.15 - 15.45 - Genetics of Human Pigmentation - Ian Jackson, UK
  • 15.45 – 16.15 - How Does UV Induce Melanoma? - Amaya Viros Usandizaga, UK
  • 16.15- 16.45 - From Susceptibility to Skin Cancer; MC1R And Beyond - Eugene Healy, UK
  • 16.45 - 17.15 - Coffee break
  • 17.15 - 18.45 - A bridge between melanocyte pathology and physiology – Session 2
    • Chair: Alessandra Napolitano, Marie Dominique Galibert, Chris Marine
  • 17.15 - 17.35 New insigths in vitiligo, which therapeutic perspectives? - Thierry Passeron, France
  • 17.35 - 17.55 - Redox Properties of Melanin and its Potential for Drug Interactions - Gregory Payne, US
  • 17.55 - 18.15 - From melanocyte to melanoma - Shain Alan Hunter, US
  • 18.15 - 18.45 - Do we understand why Melanoma is a Case Point for Cancer Immunotherapy?- Pierre Coulie, Belgium
  • 18.45 - 19.30 - Fritz Anders Award Lecture
    Chair: Lluis Montoliu, Ian Jackson
    • Imaging and targeting (pre)metastatic niches in melanoma - Marisol Soengas, Spain
  • 19.30 - 21.00 - Walking Dinner - Poster Session

13 SEPTEMBER

A) CLINICAL SESSIONS – Salle Roi Baudouin

  • 09.00 - 09.30 - A bridge between the Pathology and Physiology of the Melanocyte
    • Chair: Véronique del Marmol, Eugene Healy
  • 09.00 – 09.30 - What a dermatologist should know about melanocyte biology? - Markus Böhm, Germany
  • 09.30 – 10.15 - Melanocytic Lesions in Childhood
    • Chair: Veronica Kinsler, Pierre Vabres
  • 09.30- 09.45 - A diagnostic algorithm for pigmented macules in childhood - Pierre Vabres, France
  • 09.45 - 10.15 - Essential update on congenital melanocytic naevi - Veronica Kinsler, UK
  • 10.15 – 10.45 - Update on Melasma
    • Chair: Markus Böhm, Mariano Suppa
  • 10.15-10.45 - Melasma: Physiopathogenesis and current medical and physical therapeutical approach - Thierry Passeron, France
  • 10.45 - 11.15 - Coffee Break
  • 11.15 – 13.00 - Vitiligo and other Hypopigmentation Disorders
    • Chair: Khaled Ezzedine, Mauro Picardo, Nanja van Geel
  • 11.15 - 11.45 - Hypopigmentation: differential diagnosis - Thierry Passeron, France
  • 11.45 – 12.15 - Vitiligo : Update on physiopathogenesis and new therapeutical approach - Mauro Picardo, Italy
  • 12.15- 12.45 - Childhood and adult Vitiligo : clinical presentation and therapeutical approach - Khaled Ezzedine, France
  • 12.45 – 13.00 - New development in outcome measures for vitiligo - Nanja Van Geel, Belgium
  • 13.00- 14.00 - Lunch Break
  • 14.00– 15.20 - Melanoma Prevention / Non-invasive Imaging/Monitoring High risk patients
    • Chair: Josep Malvehy, Mariano Suppa, Caterina Longo
  • 14.00 - 14.15 - Melanoma prevention: what works and what can we do better?- Ana Maria Forsea, Romania
  • 14.15 - 14.35 - Dermoscopy of melanocytic lesions: what’s new? - Caterina Longo
  • 14.35 – 14.55 - Non-invasive techniques and melanocytic lesions: what is the current and future clinical application for these devices? - Josep Malvehy, Spain
  • 14.55 - 15.20 - Monitoring High risk patients- a practical approach - Ana Maria Forsea, Romania
  • 15.20 - 16.00 - Coffee break - Come and see my poster / Clinical cases
  • 16.00 – 17.45 - Melanoma: Epidemiology / Genetic counseling and therapy
    • Chair: Eduardo Nagore, Bart Neyns, Céleste Lebbe
  • 16.00 -16.15 - Melanoma Epidemiology update - Sara Gandini, Italy
  • 16.15 - 16.30 - What genetic counselling should be given for familial melanoma? - Susana Puig, Spain
  • 16.30 -16.45 - Melanoma - Update on lentigo maligna treatment - Eduardo Nagore, Spain
  • 16.45 - 17.00 - Current guidelines for melanoma imaging and follow up - Lieve Brochez, Belgium
  • 17.00 - 17.30 - Update on metastatic melanoma treatment - Bart Neyns, Belgium
  • 17.30 - 17.45 - Management of cutaneous toxicities of melanoma new therapies - Céleste Lebbe, France

13 SEPTEMBER

B) RESEARCH SESSIONS – Auditorium Albert II

PIGMENT CELL BIOLOGY

  • 08.30 - 10.00 - From melanin synthesis to function
    • Chair: Alessandra Napolitano, José Carlos Borrón, Tadeusz Sarna
  • 08.30 - 08.50 - Photo- and Thermal-induced Modifications/Degradations of Eumelanin and Pheomelanin - Shosuke Ito, Japan
  • 08.50 - 09.10 - How structure determines the properties of melanin pigments: an overview - Lucia Panzella, Italy
  • 09.10 - 09.20 - Characterization of the pigment organelle in keratinocytes - Silvia Benito Martinez, Spain
  • 09.20 - 09.30 - Physical parameters of melanoma melanosomes – possible link between granule tiffness and melanoma cell invasion - Michal Sarna, Poland
  • 09.30 - 09.40 - PDo melanocytes derived from human iPS cells reproduce their pigmented phenotype in 3D skin model? - Catherine Cohen, France
  • 09.40 - 09.50 - 3, 4, 5-trimethoxy cinnamate thymol ester, a safe and promising compound to regulate skin pigmentary disorder - Jae Sung Hwang, South Korea
  • 09.50 - 10.00 - Polyamines: novel regulators of human epidermal pigmentation - Leah Vardy, UK
  • 10.00 – 10.30 - Coffee break
  • 10.30 - 11.30 - Pigmentation genetic and disorders
    • Chair: Ian Jackson, Lluis Montoliu, Muriel Cario
  • 10.30 - 10.45 - DCT mutations in patients with oculocutaneous albinism - Benoit Arveiler, France
  • 10.45 - 11.00 - Keratin 5 dysregulation in pigmentary disorders - Muriel Cario, France
  • 11.00 - 11.15 - mTOR-related hypomelanosis of Ito: phenotypic spectrum - Virginie Carmignac, France
  • 11.15 - 11.30 - Genetic basis of mosaic pigmentary disorders of the skin and how to detect them: the M.U.S.T.A.R.D. cohort’s experience - Arthur Sorlin, France
  • 11.30 - 12.45 - Melanoma and Genetics
    • Chair: Eugene Healy, Véronique Bataille
  • 11.30 - 11.45 - Sex difference in melanoma - Susana Puig, Spain
  • 11.45 - 12.00 - Melanoma biology in the elderly - Amaya Viros Usandizaga, UK
  • 12.00 - 12.15 - Analysis of melanoma susceptibility genes in a large multicenter cohort of childhood and adolescent patients - Cristina Pellegrini, Italy
  • 12.15 - 12.30 - TERT promoter mutation subtypes and survival in stage I and II melanoma patients - Rajiv Kumar,Germany
  • 12.30 - 12.45 - The genetic evolution of metastatic uveal melanoma - Alan Hunter Shain, US
  • 12.45 – 14.00 - Lunch break - Come and see my poster
  • 14.00 - 14.45 - Development and biology of the melanocyte lineage
    • Chair: Lionel Larue, Veronica Kinsler
  • 14.00 - 14.20 - Human embryonic stem derived melanocyte - Lukas Sommer, Switzerland
  • 14.20 - 14.30 - The loss of dicer affects the integrin-mediated migration of melanocytes and their homing in the hair bulb - Juliette Bertrand, France
  • 14.30 - 14.40 - Characterization of the spot mouse model of waardenburg syndrome type 4 reveals two distinct lineages of ckit-positive cells in the hair follicle - Grégoire Bonnamour, Canada
  • 14.45 - 16.15 - Regulators of Melanoma progression
    • Chair: Pierre Close, Colin Goding
  • 14.45 - 15.05 - Transcriptional co-repressor CHD4 links epigenetics to glycolysis regulating proliferation of melanoma and other cancer cells - Irwin Davidson, France
  • 15.05 - 15.25 - ZEB transcription factors: an intrinsic balance controlling melanoma plasticity - Geert Berx, Belgium
  • 15.25 - 15.40 - BRN2 is a non-canonical melanoma tumor-suppressor - Lionel Larue, France
  • 15.40 - 16.00 - AhR transcription factor orchestrates melanoma progression - Marie-Dominique Galibert, France
  • 16.00 - 16.10 - NRF2 maintains melanoma growth by regulating stress-induced resistance factors - Christina Jessen, Germany
  • 16.15 – 16.45 - Coffee Break - Come and see my poster
  • 16.45 - 17.45 - Melanoma- microenvironment – immune response
    • Chair: Cedric Delevoye, Mauro Picardo, Rosalie Luiten
  • 16.45 - 17.00 - Identification of a new player in immunity against melanoma - Yann Cheli , France
  • 17.00 - 17.15 - RAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1 - Svenja Meierjohann, Germany
  • 17.15 - 17.25 - Hypoxia differentially affects (ifng-induced) regulation of pd-l1 expression in melanoma cells - Walbert Bakker, Netherlands
  • 17.25 - 17.35 - The PI3K pathway induced by a-MSH hormone exerts an inhibitory effect on melanogenesis - Vittoria Maresca, Italy
  • 17.45 - 18.45 - ESPCR General Assembly

14 SEPTEMBER

A) RESEARCH SESSION – MELANOMA – Salle Roi Baudouin

  • 08.45 – 10.00 - Phenotypic-switching and melanoma cell reprogramming
    • Chair: Céleste Lebbe, Marie-Dominique Galibert, Pierre Close
  • 08.45 - 09.05 - Phenotype-switching in melanoma - Colin Goding, UK
  • 09.05 - 09.25 - In vivo monitoring of phenotype switching during melanoma progression and metastatic dissemination - Chris Marine, Belgium
  • 09.25 - 09.45 - Codon - Specific mRNA translation reprogramming in melanoma - Pierre Close, Belgium
  • 09.45 - 09.55 - High tyrosine promotes an early switch from a proliferative/differentiated towards an invasive/undifferentiated phenotype in melanoma cells and affects the establishment of primary cultures - Ahmad Najem, Belgium
  • 10.00 – 10.30 - Coffee break
  • 10.30 – 12.00 - MELANOMA therapeutic and resistance
    • Chair: Susana Puig, Chris Marine, Ghanem Ghanem
  • 10.30 - 10.50 - Overcoming resistance to immunotherapy - Daniel Peeper, Belgium
  • 10.50 - 11.10 - Acquired immunotherapy resistance of melanoma arising through loss of interferon responsiveness can be overcome with salvage virotherapy - Janne Ruotsalainen, Finland
  • 11.10 - 11.20 - Defining the mechanisms of selective mRNA translation regulation during resistance of melanoma to targeted therapies - Najla El Hachem, Belgium
  • 11.20 - 11.30 - Epigenetic regulation underlying melanoma resistance to MAPK signaling inhibitors - Thomas Strub, France
  • 11.30 - 11.40 - Melanoma drug tolerance and resistance at single cell resolution - Florian Rambow, Belgium
  • 11.40 – 12.00 - Closing remarks
    • Véronique del Marmol, Lluis Montoliu

14 SEPTEMBER

B) INTERACTIVE DERMOSCOPY COURSE: MELANOCYTIC LESIONS THROUGHOUT LIFE – Auditorium Albert II

  • 09.00 – 12.30 - Melanocytic Lesions Throughout Life
    • Chair: Isabelle Tromme, Mariano Suppa
  • 9.00 - 9.30 - Dermoscopy of melanocytic lesions in children - Josep Malvehy, Spain
  • 9.30 - 10.00 - Dermoscopy of melanocytic lesions in adults - Katrien Vossaert, Belgium
  • 10.00 - 10.30 - Dermoscopy of melanocytic lesions in the elderly - Caterina Longo, Italy
  • 10.30 - 10.35 - Euromelanoma Award
    • Presented by Véronique del Marmol (Chair of Euromelanoma) and Aimilios Lallas (Secretary General of the International Dermoscopy Society, IDS)
  • 10.35 - 10.50 - Euromelanoma Award
    • Skin parameter maps: enhanced visualisation of pigment and vasculature in multispectral dermoscopy Laudine Janssen and Marjan Garmyn, Belgium
    • 10.50 – 11.20 - Coffee break
    • 11.20 - 12.10
      • Interactive session: best cases, quiz and discussion
      • Chair: Aimilios Lallas, Greece
      • Cases by: All faculties
    • 12.10 - 12.30 - Closing remarks- Mariano Suppa, Belgium